ATE239745T1 - Nitrid-heterokomplexe von radioaktiven übergangsmetallen - Google Patents

Nitrid-heterokomplexe von radioaktiven übergangsmetallen

Info

Publication number
ATE239745T1
ATE239745T1 AT97947953T AT97947953T ATE239745T1 AT E239745 T1 ATE239745 T1 AT E239745T1 AT 97947953 T AT97947953 T AT 97947953T AT 97947953 T AT97947953 T AT 97947953T AT E239745 T1 ATE239745 T1 AT E239745T1
Authority
AT
Austria
Prior art keywords
radioactive
radioactive transition
transition metal
transition metals
present
Prior art date
Application number
AT97947953T
Other languages
English (en)
Inventor
Adriano Duatti
Cristina Bolzati
Licia Uccelli
Fiorenzo Refosco
Francesco Tisato
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Application granted granted Critical
Publication of ATE239745T1 publication Critical patent/ATE239745T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/50Organo-phosphines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0476Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/50Organo-phosphines
    • C07F9/5004Acyclic saturated phosphines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ceramic Products (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Peptides Or Proteins (AREA)
AT97947953T 1996-12-18 1997-12-16 Nitrid-heterokomplexe von radioaktiven übergangsmetallen ATE239745T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33855396 1996-12-18
PCT/JP1997/004626 WO1998027100A1 (en) 1996-12-18 1997-12-16 Radioactive transition metal nitride hetero-complex

Publications (1)

Publication Number Publication Date
ATE239745T1 true ATE239745T1 (de) 2003-05-15

Family

ID=18319265

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97947953T ATE239745T1 (de) 1996-12-18 1997-12-16 Nitrid-heterokomplexe von radioaktiven übergangsmetallen

Country Status (13)

Country Link
US (2) US6270745B1 (de)
EP (1) EP0949265B1 (de)
JP (1) JP3935218B2 (de)
KR (1) KR100554563B1 (de)
AT (1) ATE239745T1 (de)
AU (1) AU730120B2 (de)
CA (1) CA2275451C (de)
DE (1) DE69721820T2 (de)
DK (1) DK0949265T3 (de)
ES (1) ES2193407T3 (de)
NZ (1) NZ335950A (de)
PT (1) PT949265E (de)
WO (1) WO1998027100A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855867A (en) * 1995-03-29 1999-01-05 The Curators Of The University Of Missouri Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
AU3922601A (en) * 2000-01-28 2001-08-07 Molypharma, S.A. A radiopharmaceutical for radionuclide tumor therapy
DE60136073D1 (de) * 2000-07-28 2008-11-20 Nihon Mediphysics Co Ltd Technitium-99m nitrid hetero-komplex radiopharmazeutisches mittel zur bilderzeugung
JP4266827B2 (ja) 2001-12-20 2009-05-20 サソル テクノロジー (ピーティーワイ)リミテッド クロムを主成分とした触媒を使用したオレフィン類の三量化およびオリゴマー化
US8980870B2 (en) * 2002-09-24 2015-03-17 Boehringer Ingelheim International Gmbh Solid telmisartan pharmaceutical formulations
EP1417977A1 (de) * 2002-11-07 2004-05-12 BRACCO IMAGING S.p.A. Radioaktive Übergangsmetall-Imido-Heterodiphosphinkomplexe; deren Herstellung und radiopharmazeutische Zusammensetzungen
WO2004096735A2 (en) * 2003-05-02 2004-11-11 Kamaluddin Abdur-Rashid Transfer hydrogenation processes and catalysts
JP2008037752A (ja) * 2004-11-19 2008-02-21 Nihon Medi Physics Co Ltd 新規放射性テクネチウム−ビスホスフィノアミン錯体および該錯体を含む放射性画像診断剤
WO2006080993A1 (en) * 2004-12-08 2006-08-03 Purdue Research Foundation Novel cationic metal complex radiopharmaceuticals
WO2007083395A1 (en) 2006-01-20 2007-07-26 Nihon Medi-Physics Co., Ltd. Intermediate compound of technetium nitride complex for radiodiagnostic imaging
US20130195756A1 (en) 2012-01-31 2013-08-01 General Electric Company 99mTc IMAGING AGENTS AND METHODS OF USE
WO2018109164A1 (en) 2016-12-15 2018-06-21 Bracco Imaging Spa Method for labeling of sensitive and thermosensitive targeting biomolecules with technetium based compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8723438D0 (en) * 1987-10-06 1987-11-11 Amersham Int Plc Cationic complexes of technetium-99m
WO1989008657A2 (fr) * 1988-03-09 1989-09-21 Cis Bio Internatonal Preparation de complexes nitruro utilisables comme produits radiopharmaceutiques
FR2664166A1 (fr) 1990-07-04 1992-01-10 Cis Bio Int Procede de preparation de complexes nitruro de metaux de transition utilisables comme produits radiopharmaceutiques ou pour la synthese de nouveaux produits radiopharmaceutiques.
FR2679452B1 (fr) 1991-07-22 1993-11-12 Cis Bio International Produit radiopharmaceutique ayant notamment un tropisme cerebral, comportant un complexe nitruro d'un metal de transition, et son procede de preparation.
JPH07110869A (ja) 1993-10-12 1995-04-25 Fuji Xerox Co Ltd 図形編集装置

Also Published As

Publication number Publication date
JP3935218B2 (ja) 2007-06-20
PT949265E (pt) 2003-08-29
EP0949265B1 (de) 2003-05-07
KR20000057661A (ko) 2000-09-25
US6270745B1 (en) 2001-08-07
DK0949265T3 (da) 2003-08-11
NZ335950A (en) 2000-06-23
AU5412898A (en) 1998-07-15
EP0949265A1 (de) 1999-10-13
CA2275451C (en) 2007-01-02
AU730120B2 (en) 2001-02-22
WO1998027100A1 (en) 1998-06-25
US20020048549A1 (en) 2002-04-25
DE69721820T2 (de) 2004-02-26
CA2275451A1 (en) 1998-06-25
ES2193407T3 (es) 2003-11-01
KR100554563B1 (ko) 2006-03-03
DE69721820D1 (de) 2003-06-12
EP0949265A4 (de) 2001-03-07

Similar Documents

Publication Publication Date Title
ATE239745T1 (de) Nitrid-heterokomplexe von radioaktiven übergangsmetallen
MY110526A (en) Thioether conjugates
HU9302762D0 (en) N-sulfonyl-2-oxoindole derivatives being effective on vasopressin and/or oxitocin receptors
DK0906907T3 (da) Forbindelser, der potenserer retinoid
ATE272608T1 (de) Bicyclo (2.2.1) heptane und verwandte verbindungen
EP0976748A4 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
ES2193154T3 (es) Procedimiento para la preparacion de 9-desoxotaxanos.
ZA916268B (en) Tricyclic compound or salts thereof,method for producing the same and antimicrobial agent containing the same
MX9604368A (es) Antagonistas de receptores de endotelina.
MX9304868A (es) 27-hidroxirapamicina, derivados de la misma y composicion farmaceutica que la contiene.
NO982873D0 (no) 1-metylkarbapenemderivater
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
DK0613687T3 (da) Anvendelse af pregnanderivat til behandling af tumorer
FR2688118B1 (fr) Nouvelles compositions fongicides a base d'inhibiteurs de la biosynthese des sterols.
ATE244023T1 (de) Ternäre radiopharmazeutische komplexe
EP0974347A4 (de) Antivirale mittel
NO994135L (no) Kinoksalindioner
TW340788B (en) Ester compounds and household insects-controlling agents containing the same as an active ingredient
ES2078337T3 (es) Derivado de sulfonamida y composicion farmaceutica que lo contiene.
IT8983445A0 (it) Procedimento di abbattimento di soluzioni contenenti idrossido di ammonio particolarmente per il recupero dell'ammoniaca da soluzioni esauste.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0949265

Country of ref document: EP

REN Ceased due to non-payment of the annual fee